GeneDx Holdings Corp. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their LossesGlobeNewsWire • 05/05/26
GeneDx Holdings Corp. (WGS) Reports Q1 Loss, Lags Revenue EstimatesZacks Investment Research • 05/04/26
GeneDx Reports First Quarter 2026 Financial Results and Updates Full-Year OutlookBusiness Wire • 05/04/26
GENEDX HOLDINGS (WGS) Upgraded to Strong Buy: Here's What You Should KnowZacks Investment Research • 03/24/26
Cathie Wood Just Bought This Small Cap Stock Seven Days Straight: Should Investors Take Note?Benzinga • 03/12/26
GeneDx Holdings Corp. (WGS) Presents at Barclays 28th Annual Global Healthcare Conference TranscriptSeeking Alpha • 03/11/26
Landmark Study Shows Average Cost Savings of $80,000 Per Child and Overall Improved Health Outcomes Following GeneDx Exome and Genome TestingBusiness Wire • 03/11/26
WGS, Zevra Partner to Launch Genetic Testing for Niemann-Pick Type CZacks Investment Research • 03/11/26
GeneDx to Launch Genetic Testing Program with Zevra Therapeutics to Support Patients with Suspected Niemann-Pick Disease Type CBusiness Wire • 03/10/26
Wall Street Analysts Believe GENEDX HOLDINGS (WGS) Could Rally 77.81%: Here's is How to TradeZacks Investment Research • 03/09/26
GeneDx to Present 18 Abstracts at ACMG 2026, Showcasing the Scale of GeneDx Infinity™ and Real-World Genomic LeadershipBusiness Wire • 03/09/26
Down 25% in 4 Weeks, Here's Why GENEDX HOLDINGS (WGS) Looks Ripe for a TurnaroundZacks Investment Research • 03/03/26
GeneDx's Chief Operating Officer Sold Nearly 6,000 Shares. Is the Stock a Buy or Sell?The Motley Fool • 02/26/26
HALPER SADEH LLC ENCOURAGES GENEDX HOLDINGS CORP. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTSPRNewsWire • 02/26/26